Filing Flows

Filing Flows › SeaStar Medical Holding (ICU) › Q2 2026 › vs Q1 2026

SeaStar Medical Holding (ICU) Q2 2026 vs Q1 2026 (quarter over quarter)

SeaStar Medical Holding's revenue rose $120K (+24%) from $495K in Q1 2026 to $615K in Q2 2026.

SeaStar Medical Holding, Q2 2026: revenue $615K (+82% year over year), operating margin -616.4%, net loss $3.7M, operating cash flow −$3.0M. The chart draws each line against Q1 2026, the increases inside each band.

SeaStar Medical Holding: what changed, Q2 2026 vs Q1 2026SeaStar Medical Holding: what changed, Q2 2026 vs Q1 2026Operating costs$308KCosts & expenses$305KOperating cash sources$300KCash used in operations$233KNet loss$209KNet loss absorbed$209KResearch & development$176KGeneral & admin$124KWorking capital & other$67KOther income, net−$24K

Every line

LineQ2 2026Q1 2026Change%
Revenue$615K$495K$120K+24%
Other income, net$61K$85K−$24K-28%
Net loss$3.7M$3.5M$209K+6%
Costs & expenses$4.4M$4.1M$305K+7%
Operating costs$4.4M$4.1M$308K+8%
Cost of revenue$54K$46K$8K+17%
Research & development$2.5M$2.3M$176K+8%
General & admin$1.8M$1.7M$124K+7%
Operating cash sources$3.7M$3.4M$300K+9%
Working capital & other$736K$669K$67K+10%
Cash used in operations$3.0M$2.8M$233K+8%
Net loss absorbed$3.7M$3.5M$209K+6%

Questions

How much did SeaStar Medical Holding's revenue grow quarter over quarter in Q2 2026?

SeaStar Medical Holding's revenue rose $120K (+24%) from $495K in Q1 2026 to $615K in Q2 2026.

Q2 2026 results → · Compare in the interactive Sankey →